Biotech Stocks Facing FDA Decision In July 2019

Pending Drug Approvals
Pending Drug Approvals

So far this year, i.e, January to June, only 12 novel drugs have been approved compared to 20 during the same period last year.

Now, let's take a look at the biotech stocks awaiting regulatory decisions in July.